Circulating mortalin autoantibody--a new serological marker of liver cirrhosis

scientific article published on 24 April 2015

Circulating mortalin autoantibody--a new serological marker of liver cirrhosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12192-015-0592-1
P932PMC publication ID4463917
P698PubMed publication ID25905813
P5875ResearchGate publication ID275358915

P50authorRenu WadhwaQ55149577
Sunil C KaulQ55743788
John M. LukQ42935545
P2093author name stringNishant Saxena
Wen-Jing Lu
P2860cites workTP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.Q53238636
Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survivalQ80976046
Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patientsQ95367142
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis CQ24563264
Decoding cell death signals in liver inflammationQ26823299
Hepatocellular carcinomaQ29615765
Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.Q33302500
Identification and functional characterization of nuclear mortalin in human carcinogenesis.Q34138936
Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver diseaseQ34605692
An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?Q35025904
Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapyQ35092706
Induction of Heat Shock Proteins and Antioxidant Enzymes in 2,3,7,8-TCDD-Induced Hepatotoxicity in RatsQ36479138
Diagnosis and epidemiology of cirrhosisQ37540941
Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cellsQ37680211
Circulating markers of liver fibrosis progression.Q37732860
Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin.Q39619016
Rescue of F508del-CFTR by RXR motif inactivation triggers proteome modulation associated with the unfolded protein responseQ39756792
Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis.Q40327109
Extramitochondrial localization of mortalin/mthsp70/PBP74/GRP75.Q40861255
Mortalin is a prognostic factor of gastric cancer with normal p53 functionQ44263599
Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosisQ45076019
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.Q45089361
Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohortQ45102502
Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysisQ46642884
Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer.Q50764946
P433issue4
P921main subjectautoantibodyQ785022
P304page(s)715-719
P577publication date2015-04-24
P1433published inCell Stress & ChaperonesQ13458649
P1476titleCirculating mortalin autoantibody--a new serological marker of liver cirrhosis
P478volume20

Reverse relations

Q42577013Mitochondrial Hsp70 and the troubles of nomenclature: leaving behind tradition to gain intuitiveness and claritycites workP2860